Ethical considerations in clinical neuroscience: Current concepts in neuroclinical trials

Stroke

Volumn 27, Issue 10, 1996, Pages 1903-1909

  Alves, Wayne A ^a   Macciocchi, Stephen N ^b,c  

^a Neuroclinical Trials Center   (United States)

^b UNIVERSITY OF VIRGINIA   (United States)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

clinical trials; ethics, medical; informed consent

Indexed keywords

CLINICAL PRACTICE; INFORMED CONSENT; MEDICAL ETHICS; MEDICAL RESEARCH; NEUROSCIENCE; PRACTICE GUIDELINE; PRIORITY JOURNAL; RANDOMIZATION; REVIEW; RISK BENEFIT ANALYSIS; SAMPLING;

EID: 0029778835     PISSN: 00392499     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.STR.27.10.1903     Document Type: Review

References (45)

1. Alexander L. The Treatment of Shock From Prolonged Exposure to Cold, Especially in Water. Washington, DC: Combined Intelligence Objectives Subcommittee. Office of the Publication Board, Department of Commerce. 1946; Target No. 24, Report No. 250.
2. Berger RL. Nazi science: the Dachau hypothermia experiments. N Engl J Med. 1990;322:1435-1440.
3. Trials of War Criminals Before the Nuremburg Military Tribunal. Vol 2, The Medical Case. Washington, DC: US Government Printing Office, 1948.
4. Commission, Report, and Recommendations: Research Involving Those Institutionalized as Mentally Infirm. Washington. DC: US Dept of Health, Education, and Welfare publication (OS) 78-0006; 1978.
5. Commission, Report and Recommendations: Institutional Review Boards. Washington, DC: US Dept of Health, Education, and Welfare publication (OS)78-008; 1978.
6. Commission: The Belmont Report: Ethical Principals and Guidelines for the Protection of Human Subjects of Research. Washington, DC: US Dept of Health, Education, and Welfare publication (OS)78-0012; 1978.
7. US Department of Health and Human Services Rules and Regulations. 45CFR46, 14.116, 1983.
8. Hellman S, Hellman DS. Of mice but not men: problems of the randomized clinical trial. N Engl J Med. 1994;324:1585-1589.
9. Katz J. Human experimentation and human rights. St Louis Univ Law J. 1993;38:7-54.
10. Rothman DJ. Ethics in human experimentation: Henry Beecher revisited. N Engl J Med. 1987;317:1195-1199.
11. Schafer A. The ethics of the randomized clinical trial. N Engl J Med. 1982;307:719-724.
12. Weinstein MC. Allocation of subjects in medical experiments. N Engl J Med. 1974;291:1278-1285.
13. Katz J. Ethics and clinical research revisited: a tribute to Henry K. Beecher. Hastings Center Report. 1993;23:31-39.
14. Freedman B. Equipoise and the ethics of clinical research. N Engl J Med. 1987;317:141-145.
15. Freedman B. A response to a purported ethical difficulty with randomized clinical trials involving cancer patients. J Clin Ethics. 1992;3:231-234.
16. Kopelman L. Consent and randomized clinical trials: are there moral or design problems? J Med Philos. 1986;11:317-345.
17. Gelmers HJ, Gorter K, de Weerdt CJ, Weizer HJ. A controlled trial of nimodipine in acute ischemic stroke. N Engl J Med. 1988;318: 203-207.
18. Ohman J, Heiskanen O. Effects of nimoclopine on the outcome of patients after aneurysmal subarachnoid hemorrhage. J Neurosurg. 1988;69:683-686.
19. Oczkowski WJ, Hachinski VC, Bogousslavsky J, Barnett HJ, Caruthers SG. A double-blind, randomized trial of PY108-068 in acute ischemic cerebral infarction. Stroke. 1989;20:604-608.
20. Petruk KC, West M, Mohr G, Benoit BG, Gentilli F, Disney LB, Khan M, Grace M, Holness RD. Nimodipine treatment in poor-grade aneurysm patients: results of a multicenter double-blind placebo-controlled trial. J Neurosurg. 1988;68:505-517.
21. Protecting Human Research Subjects. Office for Protection From Research Risk Institutional Review Guidebook. Washington, DC: US Government Printing Office Superintendent of Documents, Mailstop SSOP 20402-9328; 1993: sec3/p1-9; sec4/p22-26; sec4/p26; sec4/ p25; sec4/p23; sec4/p16; sec3/p16; sec3/p16.
22. Meslin E. Protecting human subjects from harm through improved risk judgments. IRB: A Review of Human Subjects Research. 1990;12:7-10.
23. Levine RJ. Clarifying the concepts of research ethics. Hastings Center Report. 1979;6:21-26.
24. Simel DL, Feussner JR. Clinical trials of informed consent. Control Clin Trials. 1992;13:321-324.
25. Connelly RJ. Deception and the placebo effect in biomedical research. IRB: Review of Human Subjects Research. 1987;9:5-7.
26. Chuang-Stein C. A new proposal for benefit-less risk analysis in clinical trials. Control Clin Trials. 1994;15:30-43.
27. Byar DP, Simon RM, Friedewald WT, Schlesselman JJ, DeMets DL, Ellenberg JH, Gail MH, Ware JH. Randomized clinical trials: perspectives on some recent ideas. N Engl J Med. 1976;295:74-80.
28. Parmar MK. Pitfalls and biases in the reporting and interpretation of the results of clinical trials. Lung Cancer. 1994;10(suppl 1):S143-S150.
29. Rabeneck L, Viscoli CM, Horowitz RI. Problems in the conduct and analysis of randomized clinical trials. Arch Intern Med. 1992;152: 507-512.
30. Schafer A. The randomized clinical trial: for whose benefit. IRB: Review of Human Subject Research. 1985;7:4-6.
31. Choi SC, Smith PJ, Becker DP. Early decision in clinical trials when the treatment differences are small. Control Clin Trials. 1985;6: 280-289.
32. Bartlett RH, Roloff DW, Cornell RG. Extracorporal circulation in neonatal respiratory failure: a prospective randomized study. Pediatrics. 1985;76:479-487.
33. Bronowski J. Science and Human Values. New York, NY: Harper Row; 1965:58.
34. Brody H. Placebos and the Philosophy of Medicine. Chicago, Ill: University of Chicago Press; 1980.
35. Rothman KJ, Michels KB. The continuing unethical use of placebo controls. N Engl J Med. 1994;331:394-398.
36. Beauchamp TL, Childress JF. Principles of Biomedical Ethics. New York, NY: Oxford University Press; 1989:74-116.
37. Rosner F. The ethics of randomized clinical trials. Am J Med. 1987;82:283-290.
38. Taub HA. Comprehension of informed consent for research: issues and directions for future study. IRB: Review of Human Subjects Research. 1986;8:7-10.
39. Duffy TM, Kabance P. Testing readable writing approach to text revision. J Educ Psychol. 1982;74:733-748.
40. US Food and Drug Administration Rules And Regulations 21 CFR 56, Federal Register 46 (January 27, 1981), 8975; revised 1991 (Federal Commission Policy) Federal Register 56 (June 18, 1991), 28003.
41. US Food and Drug Administration Rules And Regulations 21 CFR 56, Federal Register 46 (January 27, 1981), 8975; revised 1991 (Federal Commission Policy) Federal Register 56 (June 18, 1991), 28003.
42. Emanuel EJ, Emanuel LL. Proxy decision making for incompetent patients. JAMA. 1992;267:2067-2071.
43. Fost N, Robertson JA. Deferring consent with incompetent patients in an intensive care unit. IRB: Review of Human Subjects Research. 1980;2:5-6.
44. Beauchamp TL. The ambiguities of deferred consent. IRB: Review of Human Subjects Research. 1980;2:6-9.
45. Levine RJ. Deferred consent. Control Clin Trials. 1991;12:546-550.